Name: Germline Predisposition to Myeloid Neoplasms – Case discussions
Start: 2026-03-05T15:00:00+01:00
End: 2026-03-05T16:00:00+01:00

3:00 pm

March 5 @ 3:00 pm - 4:00 pm

Why a Nordic AML Group?

Recognizeable systems in Nordic countries, similar treatment traditions, one working market.

Unmet need to improve AML therapy through research and clinical trials.

URL

This field is for validation purposes and should be left unchanged.

Name(Required)

First Last

Email(Required)

Enter Email Confirm Email

Privacy(Required)

I agree with the storage and handling of my data by this website.

CAPTCHA